National Commission on COVID-19 Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
National Commission on COVID-19 Act
This bill establishes the National Commission on COVID-19 (i.e., coronavirus disease 2019) in the legislative branch to assess the emergence, spread, and response to the disease in the United States and sets forth its powers, duties, funding, and membership. The commission must issue a report with findings and recommendations concerning, among other topics,
- surveillance, testing, treatment, and vaccines;
- medical devices, drugs, and other supplies, including personal protective equipment;
- preparedness and capacity of the U.S. health care system;
- certain federal laws and programs such as the Defense Production Act, the Strategic National Stockpile, and others;
- public health measures such as social distancing; and
- roles and responsibilities among federal departments, as well as coordination and communication between those departments and other entities, including state, territorial, tribal, and local governments.
The commission terminates 60 days after the submission of the final report.
Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6429: National Commission on COVID-19 Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6429/
"H.R. 6429: National Commission on COVID-19 Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6429/.
H.R. 6429, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6429/.
[H.R. 6429: National Commission on COVID-19 Act](https://openamerica.io/bill/116-HR-6429/)